76
Participants
Start Date
June 30, 2012
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
arm 1 nucleotide analogue reverse transcriptase inhibitors and boosted protease inhibitors
NRTI + PI
Arm 2 boosted protease inhibitors and maraviroc
PI + maraviroc
Arm 3 nucleotide analogue reverse transcriptase inhibitors and maraviroc
NRTI + maraviroc
St. Vincent's Hospital, Sydney
Brisbane Sexual Health and HIV Service, Brisbane
Chulalongkorn University Hospital, Bangkok
Instituto Nacional de Ciencias Medicas y Nutriciòn Salvador Zubiran, Mexico City
Universitätsklinikum Düsseldorf, Klinik für Gastroenterologie, Hepatologie und Infektiologie, MX-Ambulanz, Düsseldorf
Klinikum der Universitat Zu Koln, Cologne
Hospital Italiano de Buenos Aires, Buenos Aires
Hospital General de Agudos J M Ramos Mejia, Buenos Aires
Fundación IDEAA, Buenos Aires
Southern Alberta Clinic, Calgary
University Health Network - Toronto General Hospital, Toronto
Clinic Opus/Lori, Montreal
Nagoya Medical Center, Nagoya
Western General Hospital, Edinburgh
Brighton & Sussex University NHS Trust, Brighton
Lead Sponsor
Kirby Institute
OTHER_GOV